Abstract
146 Treatment with the oral CCR4 antagonist RPT193 results in meaningful changes in cutaneous biomarkers detected by transcriptomic profiling of tape strips
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have